4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-22-043768
President and CEO gave up 12,631 shares (to pay taxes)
- President and CEO acquired 160,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIDRON NADAV President and CEO | 2022-07-28 | Grant or award | +34,000 | 964,729 | D | ||
| KIDRON NADAV President and CEO | 2022-07-28 | Grant or award | +126,000 | 1,090,729 | D | ||
| KIDRON NADAV President and CEO | 2022-08-01 | Shares withheld for taxes | −12,631 | $8.36 | $105,595 | 1,078,098 | D |
Loading xslF345X03/doc4.xml…